1c-Abl kinase at the crossroads of healthy synaptic remodeling and synaptic dysfunction in neurodegenerative diseasesDaniela A.Gutiérrez，América Chandía-Cristi，María JoséYá?ez，Silvana Zanlungo，Alejandra R.álvarezReviews237-243
2The mechanism and relevant mediators associated with neuronal apoptosis and potential therapeutic targets in subarachnoid hemorrhageQi Tian，Sheng Liu，Shou-Meng Han，Wei Zhang，Xian-Yao Qin，Jun-Hui Chen，Cheng-Li Liu，Yu-Jia Guo，Ming-Chang LiReviews244-252
3Brain and spinal cord trauma: what we know about the therapeutic potential of insulin growth factor 1 gene therapyMaría Jose Bellini，Florencia LabombardaReviews253-257
4Functions and mechanisms of cytosolic phospholipase A2 in central nervous system traumaHao-Jie Zhang，Yi-Tuo Chen，Xin-Li Hu，Wan-Ta Cai，Xiang-Yang Wang，Wen-Fei Ni，Kai-Liang ZhouReviews258-266
5Microglia depletion as a therapeutic strategy: friend or foe in multiple sclerosis models?Victoria Sofia Berenice Wies Mancini，Anabella Ayelen Di Pietro，Laura Andrea PasquiniReviews267-272
6Cre-recombinase systems for induction of neuron-specific knockout models: a guide for biomedical researchersTetiana Shcholok，Eftekhar EftekharpourReviews273-279
7Prenatal programing of motivated behaviors: can innate immunity prime behavior?Larisa Montalvo-Martínez，Gabriela Cruz-Carrillo，Roger Maldonado-Ruiz，Luis A.Trujillo-Villarreal，Eduardo A.Garza-Villarreal，Alberto Camacho-MoralesReviews280-283
8Safety, immunogenicity, efficacy, and acceptability of COVID-19 vaccination in people with multiple sclerosis: a narrative reviewFioravante Capone，Mariagrazia Rossi，Alessandro Cruciani，Francesco Motolese，Fabio Pilato，Vincenzo Di LazzaroReviews284-288
9Simulating traumatic brain injury in vitro: developing high throughput models to test biomaterial based therapiesRaja Haseeb Basit，Jessica Wiseman，Farhana Chowdhury，Divya Maitreyi ChariReviews289-292
10Mortalin/Hspa9 involvement and therapeutic perspective in Parkinson's diseaseBaptiste Texier，Morgane Prime，Djamaa Atamena，Pascale Belenguer，Marion SzelechowskiReviews293-298
11The potential of gene therapies for spinal cord injury repair: a systematic review and meta-analysis of pre-clinical studiesCatriona J.Cunningham，Mindaugas Viskontas，Krzysztof Janowicz，Yasmin Sani，Malin E.H?kansson，Anastasia Heidari，Wenlong Huang，Xuenong BoReviews299-305
12The Wnt/β-catenin signaling: a multifunctional target for neuroprotective and regenerative strategies in Parkinson's diseaseAnnalucia Serafino，Mauro CozzolinoPerspectives306-308
13Approaches to quantify axonal morphology for the analysis of axonal degenerationAlex Palumbo，Marietta ZillePerspectives309-310
14MicroRNA-based targeting of the Rho/ROCK pathway in therapeutic strategies after spinal cord injuryTetsu Kimura，Yuta HorikoshiPerspectives311-312
15Advances in quantitative analysis of astrocytes using machine learningDemetrio Labate，Cihan KayasandikPerspectives313-314
16Synaptopathy in CHMP2B frontotemporal dementia highlights the synaptic vesicle cycle as a therapeutic targetMiranda Robbins，Emma L.ClaytonPerspectives315-316
17The role of mitochondria in the recovery of neurons after injuryTaylor McElroy，Rola S.Zeidan，Laxmi Rathor，Sung Min Han，Rui XiaoPerspectives317-318
18Turning up the NAD+-mitophagy axis to treat Alzheimer 's diseaseEvandro F.Fang，Alexander AnisimovPerspectives319
19Kainate receptors in the CA2 region of the hippocampusYuniesky Andrade-Talavera，Antonio Rodríguez-MorenoPerspectives320-321
20Understanding the timing of brain injury in fetal growth restriction: lessons from a model of spontaneous growth restriction in pigletsHannah Musco，Julie A.WixeyPerspectives322-323
